Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 4, 2008, Pages 541-548

  Courtis, Javier ^a   Rodés Cabau, Josep ^a   Larose, Eric ^a   Déry, Jean Pierre ^a   Nguyen, Can Manh ^a   Proulx, Guy ^a   Gleeton, Onil ^a   Roy, Louis ^a   Barbeau, Gerald ^a   Noël, Bernard ^a   Delarochellière, Robert ^a   Bertrand, Olivier F ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Coronary revascularization; Fractional flow reserve; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY PRESSURE; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART DEATH; HEART INFARCTION; HEART INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 41649093424     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21406     Document Type: Article

References (19)

1. Pijls NH, De Bruyne B, Peels K, Van der Voort PH, Bonnier H, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-1708.
2. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma F, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation 2001;103:2928-2934.
3. Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B. Long-term outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005;46:438-442.
4. Potvin JM, Rodés-Cabau J, Bertrand OF, Gleeton O, Nguyen CN, Barbeau G, Proulx G, DeLarochellière R, Déry JP, Batalla N, Dana A, Facta A, Roy L. Usefulness of fractional flow reserve measurements in patients with stable or unstable angina pectoris, non ST elevation and ST elevation acute myocardial infarction or atypical chest pain. Am J Cardiol 2006;98:289-297.
5. Rieber J, Jung P, Koenig A, Schiele T, Shapiro M, Hoffman U, Klauss V. Five-year follow-up in patients after therapy stratification based on intracoronary pressure measurement. Am Heart J 2007;153:403-409.
6. Legalery P, Schiele F, Seronde MF, Meneveau N, Wei H, Didier K, Blonde MC, Caulfield F, Bassand JP. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J 2005;26: 2623-2629.
7. Lindstaedt M, Yazar A, Germing A, Fritz MK, Holland-Letz T, Mugge A, Bojara W. Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. Am Heart J 2006;152:156.e1-9.
8. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, Higano S, Lim MJ, Meuwissen M, Piek JJ, Pijls N, Siebes M, Spaan AE. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory. A scientific statement from the American Heart Association committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology. Circulation 2006;114:1321-1341.
9. Silber S, Albertsson P, Fernandez-Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions: The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 2005;26:804-847.
10. Chamuleau SA, Meuwissen M, Koch KT, van Eck-Smit BL, Tio RA, Tijssen JG, Piek JJ. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. Am J Cardiol 2002;89:377-380.
11. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001;104:157-162.
12. McClish J, Ragosta M, Powers E, Barringhaus KG, Gimple LW, Fischer J, Garnett J, Siadaty M, Sarembock IJ, Samady H. Effects of acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing. Am J Cardiol 2004;93:1102-1106.
13. Meuwissen M, Chamuleau SA, Siebes M, Siebes M, Schotborgh CE, Koch KT, de Winter RJ, Bax M, de Jong A, Spaan JA, Piek JJ. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 2001;103:184-187.
14. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:1712-1719.
15. Claeys MJ, Bosmans JM, Hendrix J, Vrints CJ. Reliability of fractional flow reserve measurements in patients with associated microvascular dysfunction: Importance of flow on translesional pressure gradient. Cathetr Cardiovasc Interv 2001;54:427-434.
16. Leesar MA, Abdul-Baki T, Yalamanchili V, Hakim J, Kern M. Conflicting functional assessment of stenoses in patients with previous myocardial infarction. Catheter Cardiovasc Interv 2003;59:489-495.
17. Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG. Adequacy of intracoronary versus intravenous adenosine-induced maximal hyperemia for fractional flow reserve measurements. Am Heart J 2000;140:651-657.
18. Casella G, Leibig M, Schiele T, Schrepf R, Seelig V, Stempfle HU, Erdin P, Rieber J, König A, Siebert U, Klauss V. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 2004;148:590-595.
19. Murtagh B, Higano S, Lennon R, Matthew V, Holmes DR, Lerman A. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 2003;146:99-105.